NO20006065D0 - Cyanoiminokinoksalinderivater - Google Patents
CyanoiminokinoksalinderivaterInfo
- Publication number
- NO20006065D0 NO20006065D0 NO20006065A NO20006065A NO20006065D0 NO 20006065 D0 NO20006065 D0 NO 20006065D0 NO 20006065 A NO20006065 A NO 20006065A NO 20006065 A NO20006065 A NO 20006065A NO 20006065 D0 NO20006065 D0 NO 20006065D0
- Authority
- NO
- Norway
- Prior art keywords
- ncn
- independently
- hydrogen
- cyanoiminokinoksalinderivater
- cyanoiminoquinoxaline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15101798 | 1998-06-01 | ||
| PCT/JP1999/002822 WO1999062887A1 (en) | 1998-06-01 | 1999-05-28 | Cyanoiminoquinoxaline derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20006065D0 true NO20006065D0 (no) | 2000-11-29 |
| NO20006065L NO20006065L (no) | 2001-01-31 |
Family
ID=15509486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006065A NO20006065L (no) | 1998-06-01 | 2000-11-29 | Cyanoiminokinoksalinderivater |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6525054B1 (no) |
| EP (1) | EP1097927B1 (no) |
| JP (1) | JP3231338B2 (no) |
| KR (1) | KR20010043981A (no) |
| CN (1) | CN1304404A (no) |
| AT (1) | ATE333447T1 (no) |
| AU (1) | AU744274B2 (no) |
| BR (1) | BR9910859A (no) |
| CA (1) | CA2333515A1 (no) |
| DE (1) | DE69932441T2 (no) |
| HU (1) | HUP0102854A3 (no) |
| ID (1) | ID26809A (no) |
| IL (1) | IL139783A0 (no) |
| NO (1) | NO20006065L (no) |
| NZ (1) | NZ508280A (no) |
| PL (1) | PL344406A1 (no) |
| RU (1) | RU2217426C2 (no) |
| TR (1) | TR200003572T2 (no) |
| WO (1) | WO1999062887A1 (no) |
| ZA (1) | ZA200006838B (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100581344B1 (ko) * | 2003-05-02 | 2006-05-23 | 주식회사디엔에이링크 | 텔로머라제 활성 억제용 조성물 |
| EP2241557A1 (de) | 2009-04-02 | 2010-10-20 | Æterna Zentaris GmbH | Chinoxalin-Derivate und deren Anwendung zur Behandlung gutartiger und bösartiger Tumorerkrankungen |
| CN104177595A (zh) * | 2013-05-28 | 2014-12-03 | 海洋王照明科技股份有限公司 | 含喹喔啉基的聚合物及其制备方法和有机太阳能电池器件 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6369057B1 (en) | 1991-04-15 | 2002-04-09 | Aventis Pharma Deutschland Gmbh | Quinoxalines, processes for their preparation and their use |
| AU688459B2 (en) | 1994-04-08 | 1998-03-12 | Shionogi & Co., Ltd. | Oxopyridinylquinoxaline derivative |
| HU223945B1 (hu) * | 1994-09-27 | 2005-03-29 | Yamanouchi Pharmaceutical Co., Ltd. | 1,2,3,4-Tetrahidro-kinoxalin-dion-származékok és ezeket tartalmazó gyógyszerkészítmények |
| HUT76302A (en) | 1995-11-30 | 1997-07-28 | Chinoin Gyogyszer Es Vegyeszet | Quinoxaline derivatives, pharmaceutical compositions containing them and process for producing them |
| CA2238029A1 (en) * | 1996-03-05 | 1997-09-12 | Medinox, Inc. | Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
| AUPN842196A0 (en) | 1996-03-05 | 1996-03-28 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
-
1999
- 1999-05-28 IL IL13978399A patent/IL139783A0/xx unknown
- 1999-05-28 US US09/701,383 patent/US6525054B1/en not_active Expired - Fee Related
- 1999-05-28 NZ NZ508280A patent/NZ508280A/xx unknown
- 1999-05-28 EP EP99922540A patent/EP1097927B1/en not_active Expired - Lifetime
- 1999-05-28 CN CN99806926A patent/CN1304404A/zh active Pending
- 1999-05-28 BR BR9910859-3A patent/BR9910859A/pt not_active IP Right Cessation
- 1999-05-28 RU RU2001101155/04A patent/RU2217426C2/ru not_active IP Right Cessation
- 1999-05-28 JP JP55654899A patent/JP3231338B2/ja not_active Expired - Fee Related
- 1999-05-28 AU AU39553/99A patent/AU744274B2/en not_active Ceased
- 1999-05-28 PL PL99344406A patent/PL344406A1/xx not_active Application Discontinuation
- 1999-05-28 WO PCT/JP1999/002822 patent/WO1999062887A1/ja active IP Right Grant
- 1999-05-28 ID IDW20002390A patent/ID26809A/id unknown
- 1999-05-28 DE DE69932441T patent/DE69932441T2/de not_active Expired - Fee Related
- 1999-05-28 AT AT99922540T patent/ATE333447T1/de not_active IP Right Cessation
- 1999-05-28 KR KR1020007013611A patent/KR20010043981A/ko not_active Application Discontinuation
- 1999-05-28 CA CA002333515A patent/CA2333515A1/en not_active Abandoned
- 1999-05-28 HU HU0102854A patent/HUP0102854A3/hu unknown
- 1999-05-28 TR TR2000/03572T patent/TR200003572T2/xx unknown
-
2000
- 2000-11-22 ZA ZA200006838A patent/ZA200006838B/en unknown
- 2000-11-29 NO NO20006065A patent/NO20006065L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU3955399A (en) | 1999-12-20 |
| DE69932441T2 (de) | 2007-03-15 |
| CN1304404A (zh) | 2001-07-18 |
| EP1097927A1 (en) | 2001-05-09 |
| BR9910859A (pt) | 2001-03-13 |
| HUP0102854A2 (hu) | 2002-03-28 |
| ZA200006838B (en) | 2001-05-23 |
| NZ508280A (en) | 2002-09-27 |
| RU2217426C2 (ru) | 2003-11-27 |
| CA2333515A1 (en) | 1999-12-09 |
| ID26809A (id) | 2001-02-08 |
| HUP0102854A3 (en) | 2002-07-29 |
| EP1097927A4 (en) | 2002-08-07 |
| JP3231338B2 (ja) | 2001-11-19 |
| EP1097927B1 (en) | 2006-07-19 |
| AU744274B2 (en) | 2002-02-21 |
| DE69932441D1 (de) | 2006-08-31 |
| KR20010043981A (ko) | 2001-05-25 |
| TR200003572T2 (tr) | 2001-06-21 |
| IL139783A0 (en) | 2002-02-10 |
| WO1999062887A1 (en) | 1999-12-09 |
| PL344406A1 (en) | 2001-11-05 |
| US6525054B1 (en) | 2003-02-25 |
| NO20006065L (no) | 2001-01-31 |
| ATE333447T1 (de) | 2006-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69418704D1 (de) | Anthranilsäure derivate | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| PT870768E (pt) | Derivados azaindole-etilamina como agentes de ligacao nicotinicos aos receptores de acetilcolina | |
| GB9801690D0 (en) | Therapeutic agents | |
| DE69519469D1 (de) | Chinazolin-derivate | |
| BR9910621A (pt) | Novos compostos de imidazol 2-alquil substituìdos | |
| ID23954A (id) | Tetrahidrogama-karbolin | |
| ATE224372T1 (de) | Substituierte 6-alkylphenanthridine | |
| AR003137A1 (es) | Una composicion farmaceutica para tratar la leucemia | |
| ATE246686T1 (de) | Pyrrolocarbazolderivate | |
| NO20006065L (no) | Cyanoiminokinoksalinderivater | |
| UY26568A1 (es) | Nuevos derivados de amidas heterocíclicas | |
| PT1072601E (pt) | Derivados de 4-arilpiperidina para o tratamento de prurido | |
| ATE222583T1 (de) | Derivate substituierter amidinonaphthylester | |
| FI822706A0 (fi) | Foerfarande foer framstaellning av farmakologiskt aktiva heteroaryloxipropanolaminer | |
| ES2168119T3 (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
| AR003129A1 (es) | Derivados de bencimidazol 2-sustituidos y composiciones farmaceuticas que los comprenden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |